2026

Safety and efficacy of a sandwich total neoadjuvant therapy strategy for low-risk distal locally advanced rectal cancer: results from the TESS phase II trial.
Liu, Shuang ORCID: https://orcid.org/0000-0003-2347-413X, Lv, GuangZhao, Xu, GeYu, Wang, XiaoZhong, Zhuang, YeZhong, Bai, ShouMin, Yu, HaiNa, Wu, XiaoJun, Ye, YiJing, Luo, HuiLong, Xu, ShuoYu, Wang, QiaoXuan, Chang, Hui, Cai, PeiQiang, Pan, ZhiZhong, Gao, YuanHong, Chen, Gong and Xiao, WeiWei
MedComm 7 (7): e70807. July 2026

The protein phosphatase inhibitor LB100 targets the mesenchymal lineage of pancreatic ductal adenocarcinoma.
Murr, Janine, Schneider, Carolin, Duan, Ningjun, Köse, Hazal, Rajamani, Anantharamanan, He, Xueyang, Buchloh, Jonas, Hintze, Christian, Naik, Atharva, Goeke, Daniel, Rjasanow, Nicole, Krauß, Lukas, Nguyen, Alexandra, Widholz, Sebastian A., Schneeweis, Christian, Trozzo, Riccardo, Orben, Felix, Mueller, Sebastian, Öllinger, Rupert, Montero, Juan J., Dudek, Michael, Knolle, Percy, Kong, Bo, Ellenrieder, Volker, Contreras, Constanza Tapia, Hessmann, Elisabeth, Grade, Marian, Ghadimi, Michael, Braun, Christian J., Rad, Roland, Reichert, Maximillian, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Schmid, Roland M., Boutz, Paul L., Saur, Dieter, Wirth, Matthias ORCID: https://orcid.org/0000-0002-8340-0872, Krämer, Oliver H. and Schneider, Günter ORCID: https://orcid.org/0000-0003-1840-4508
MedComm 7 (6): e70794. June 2026